Trial Profile
PERSPECTIVES: Protelos for postmenopausal osteoporotic patients with previous therapies - an observational prospective multi-centre study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2022
Price :
$35
*
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms PERSPECTIVES
- Sponsors Servier
- 27 May 2009 New trial record